Comparison Between Hyperbaric Bupivacaine With Fentanyl vs. Hyperbaric Bupivacaine With Dexmedetomidine in Reducing Visceral Pain During Cesarean Delivery Under Spinal Anaesthesia

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

April 30, 2024

Primary Completion Date

August 31, 2024

Study Completion Date

September 30, 2024

Conditions
Visceral Pain
Interventions
DRUG

Intrathecal Bupivacaine-Fentanyl and Bupivacaine-Dexmedetomidine

In patients undergoing elective LSCS under subarachnoid block, group BF will receive 0.5% hyperbaric bupivacaine 10mg (2ml) with fentanyl 10 mcg (0.2ml) with total of 2.2 ml and group BD will receive 0.5% hyperbaric bupivacaine 10 mg with Dexmedetomidine 5mcg (0.2ml) total volume 2.2ml. Assessment of intraoperative visceral pain will be done by self-reporting of patients, who are previously educated, as poorly localized discomfort or dragging, pulling heaviness or unpleasant feeling or pain with or without nausea and will be categorized according to preformed scale.

All Listed Sponsors
lead

Tribhuvan University Teaching Hospital, Institute Of Medicine.

OTHER

NCT06367660 - Comparison Between Hyperbaric Bupivacaine With Fentanyl vs. Hyperbaric Bupivacaine With Dexmedetomidine in Reducing Visceral Pain During Cesarean Delivery Under Spinal Anaesthesia | Biotech Hunter | Biotech Hunter